vimarsana.com

Latest Breaking News On - Etesian wealth advisors inc - Page 1 : vimarsana.com

True Wealth Design LLC Cuts Stake in SK Telecom Co , Ltd (NYSE:SKM)

True Wealth Design LLC cut its holdings in SK Telecom Co., Ltd. (NYSE:SKM – Free Report) by 1.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 37,061 shares of the Wireless communications provider’s stock after selling 617 shares during the […]

United Services Automobile Association Buys 90,194 Shares of Gilead Sciences, Inc (NASDAQ:GILD)

United Services Automobile Association lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 67.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 222,985 shares of the biopharmaceutical company’s stock after acquiring an additional 90,194 shares during the […]

Hoylecohen LLC Purchases 327 Shares of Gilead Sciences, Inc (NASDAQ:GILD)

Hoylecohen LLC raised its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,830 shares of the biopharmaceutical company’s stock after acquiring an additional 327 shares during the period. […]

JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) Shares Sold by Orion Portfolio Solutions LLC

JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI) Shares Sold by Orion Portfolio Solutions LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Journey Strategic Wealth LLC Buys Shares of 2,489 Gilead Sciences, Inc (NASDAQ:GILD)

Journey Strategic Wealth LLC bought a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,489 shares of the biopharmaceutical company’s stock, valued at approximately $202,000. A number of other institutional investors also recently […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.